carbidopa and Dyskinesia, Drug-Induced

carbidopa has been researched along with Dyskinesia, Drug-Induced in 90 studies

Research

Studies (90)

Timeframe	Studies, this research(%)	All Research%
pre-1990	26 (28.89)	18.7374
1990's	25 (27.78)	18.2507
2000's	14 (15.56)	29.6817
2010's	24 (26.67)	24.3611
2020's	1 (1.11)	2.80

Authors

Authors	Studies
Arca, R; Cossu, G; di Biase, L; Di Lazzaro, V; Di Santo, A; Fasano, A; Marano, M; Marano, P; Naranian, T; Poon, YY	1
Adar, L; Case, RJ; Ellenbogen, AL; Espay, AJ; Leinonen, M; Olanow, CW; Oren, S; Orenbach, SF; Poewe, W; Stocchi, F; Yardeni, T	1
Ehm, G; Jeon, B; Kim, A; Kim, HJ; Kim, YE; Lee, WW; Yang, HJ; Yun, JY	1
Bendi, VS; Joy, S; Shou, J; Torres-Russotto, D	1
Duvvuri, S; Gray, DL; Liu, W; Papapetropoulos, S; Thayer, K	1
Abd El Fattah, MA; Badawi, GA; El Sayed, MI; Zaki, HF	1
Jackson, MJ; Jenner, P; Pearce, RK; Swart, T	1
Nagy, H; Radics, P; Takáts, A; Tamás, G; Tóth, A	1
di Biase, L; Di Lazzaro, V; Marano, M; Melgari, JM; Salomone, G; Scrascia, F	1
Fahn, S; Kestenbaum, M	1
Aschermann, Z; Bereczki, D; Dézsi, L; Dibó, G; Klivényi, P; Komoly, S; Kovács, N; Nagy, H; Takáts, A; Tóth, A; Valikovics, A; Varannai, L; Vécsei, L; Zemlényi, G	1
Antonelli, F; Buongiorno, M; Calopa, M; Cámara, A; Campolongo, A; de Fabregues-Nebot, O; Hernandez-Vara, J; Kulisevsky, J; Martí, MJ; Pascual-Sedano, B; Puente, V; Tolosa, E; Valldeoriola, F	1
Bonuccelli, U; Ceravolo, R; Frosini, D; Mazzucchi, S	1
Antonini, A; Benesh, JA; Boyd, JT; Chatamra, K; Eaton, S; Fung, VS; Hall, C; Slevin, JT	1
Dhall, R; Kreitzman, DL	1
Cannas, A; Marrosu, F; Mascia, MM; Meloni, M; Solla, P	1
Alonso-Frech, F; Catalán, MJ; Escribano, PM	1
Fung, VS; Herawati, L; Wan, Y	1
Bono, G; Garavaglia, P; Guidotti, M; Leva, S; Pianezzola, C; Raudino, F; Riboldazzi, G	1
Klivényi, P; Vécsei, L	1
Marconi, S; Stocchi, F	1
Müller, T	1
Barone, P; Jankovic, J; Kieburtz, K; Lang, AE; Olanow, CW; Poewe, W; Rascol, O; Stocchi, F; Tolosa, E	1
Bogdanov, RR; Kotov, SV; Kunitsyna, AN; Turbina, LG	1
Dotchin, C; Jusabani, A; Walker, R	1
Becker, N; Munhoz, RP; Teive, HA	1
Tarsy, D	1
Derkinderen, P; Lebouvier, T; Pouclet, H	1
Hansard, MJ; Jackson, MJ; Jenner, P; Maratos, E; Smith, LA	1
Bakay, RA; Barnhart, H; Chockkan, V; DeLong, MR; Evatt, M; Freeman, A; Green, J; Haber, M; McDonald, W; Mewes, K; Triche, S; Vitek, JL; Wahlay, N; Zhang, JY	1
Cheetham, SC; Hansard, MJ; Jackson, MJ; Jenner, P; Smith, LA	1
Krahn, M; Lang, A; Marras, C; Naglie, G; Tomlinson, G	1
Al-Barghouthy, G; Jackson, MJ; Jenner, P; Kuoppamaki, M; Olanow, W; Rose, S; Smith, LA	1
Aquilonius, SM; Askmark, H; Constantinescu, R; Dizdar, N; Holmberg, B; Jansson, R; Nilsson Remahl, AI; Nyholm, D	1
Stocchi, F	1
Hauser, RA	1
Ludin, HP; Surber, Ch	1
Hauser, RA; Schapira, AH; Simonson, W	1
Shoulson, I	1
Carvey, P; Goetz, CG; Klawans, HL	1
Casey, DE; Gerlach, J	1
Bitton, V; Melamed, E	1
Coffey, CE; Massey, EW; Olanow, CW; Ross, DR	1
Klawans, HL	1
Jacob, RG; Szekely, BC; Turner, SM	1
Matsumoto, Y; Miyamoto, T; Nakamura, S; Ohmoto, T	1
Dunner, FJ; McCalley-Whitters, M; Nasrallah, HA; Smith, RE	1
Fahn, S	2
Carvey, P; Goetz, CG; Klawans, HL; Nausieda, PA; Weiner, WJ	1
Lunn, V; Northcott, C; Yatham, LN	1
Winn, P	1
Linazasoro, G	1
Caligiuri, MP	1
Bédard, PJ; Blanchette, P; DiPaolo, T; Falardeau, P; Gagnon, C; Gomez-Mancilla, B	1
Lang, AE; Mark, MH; Sage, JI; Zimmerman, TR	1
Chase, TN; Dambrosia, JM; Peppe, A	1
Gash, DM; Kurlan, R; McDermott, M; Smith, RD; Zhang, Z	1
Carter, JH; Gancher, ST; Hammerstad, JP; Nutt, JG; Woodward, W	1
Caligiuri, MP; Lohr, JB	1
Facca, A; Sanchez-Ramos, J	1
Jackson, M; Jenner, P; Marsden, CD; Pearce, RK; Smith, L	1
Emerich, DF; Francis, JM; Lindner, MD; Plone, MA	1
Barbato, L; Berardelli, A; Bonamartini, A; Manfredi, M; Patsalos, PN; Ruggieri, S; Stocchi, F	1
Blanchet, PJ; Chase, TN; Del Dotto, P; Natté, R; van den Munckhof, P; Verhagen Metman, L	1
Capildeo, R	1
Black, KJ; Carl, JL; Hershey, T; McGee-Minnich, LA; Perlmutter, JS; Stambuk, MK	1
Desimone, R; Fiorani, M; Oldfield, EH; Papa, SM	1
Ahlskog, JE	2
Jackson, MJ; Jenner, P; Kanda, T; Kase, H; Kuwana, Y; Nakamura, J; Pearce, RK; Smith, LA	1
Sears, ES	1
List, SJ; Seeman, P	1
Feuerstein, C; Gavend, M; Pellat, J; Perret, J; Serre, F; Tanche, M	2
Cotzias, GC; McDowell, FH; Papavasilliou, PS; Rosal, VL; Sheehan, PJ	1
Bonnet, K; Friedhoff, AJ; Rosengarten, H	1
Koller, WC	1
Rodnitzky, RL	1
Carey, RJ	1
Ahlskog, JE; Wilkinson, JM	1
Bakay, RA; Byrd, LD; Colbassani, HJ; Herring, CJ; Iuvone, PM; Mandir, A; Sweeney, KM; Watts, RL	1
Berger, HJ; Horstink, MW; Pasman, JW; van't Hof, MA; Zijlmans, JC	1
Ludatscher, JI	1
Ahlskog, JE; Bell, GN; Carmichael, SW; Kelly, PJ; Stoddard, SL; van Heerden, JA	1
Luquin, MR; Obeso, JA; Vaamonde, J	1
Koller, WC; Lang, AE; Marsden, CD; Quinn, NP	1
Ahlskog, JE; Bailey, PA; Bell, GN; McManis, PG; Muenter, MD	1
Lieberman, AN	1
Friedman, A	1

Reviews

13 review(s) available for carbidopa and Dyskinesia, Drug-Induced

Article	Year
[Treatment possibilities in advanced Parkinson's disease]. Ideggyogyaszati szemle, 2013, Nov-30, Volume: 66, Issue:11-12 Topics: Administration, Oral; Age Factors; Antiparkinson Agents; Apomorphine; Carbidopa; Cognition Disorders; Deep Brain Stimulation; Dopamine Agents; Drug Tolerance; Duodenum; Dyskinesia, Drug-Induced; Gels; Humans; Infusion Pumps, Implantable; Levodopa; Parkinson Disease; Quality of Life; Severity of Illness Index	2013
Safety of IPX066 , an extended release carbidopa-levodopa formulation, for the treatment of Parkinson's disease. Expert opinion on drug safety, 2015, Volume: 14, Issue:5 Topics: Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Combinations; Dyskinesia, Drug-Induced; Half-Life; Humans; Levodopa; Parkinson Disease	2015
Current treatment and future prospects of dopa-induced dyskinesias. Drugs of today (Barcelona, Spain : 1998), 2015, Volume: 51, Issue:5 Topics: Amantadine; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Practice Guidelines as Topic; Treatment Outcome	2015
Advances in levodopa therapy for Parkinson disease: Review of RYTARY (carbidopa and levodopa) clinical efficacy and safety. Neurology, 2016, Apr-05, Volume: 86, Issue:14 Suppl 1 Topics: Administration, Oral; Animals; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Administration Schedule; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Treatment Outcome	2016
Factors associated with motor fluctuations and dyskinesia in Parkinson Disease: potential role of a new melevodopa plus carbidopa formulation (Sirio). Clinical neuropharmacology, 2010, Volume: 33, Issue:4 Topics: Antiparkinson Agents; Biological Availability; Carbidopa; Delayed-Action Preparations; Dopamine Agonists; Drug Combinations; Dyskinesia, Drug-Induced; Dyskinesias; Female; Humans; Hyperkinesis; Levodopa; Male; Parkinson Disease; Solubility; Time Factors	2010
Entacapone. Expert opinion on drug metabolism & toxicology, 2010, Volume: 6, Issue:8 Topics: Animals; Antiparkinson Agents; Biological Availability; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Half-Life; Humans; Levodopa; Nitriles; Parkinson Disease	2010
The levodopa wearing-off phenomenon in Parkinson's disease: pharmacokinetic considerations. Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:10 Topics: Animals; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Catechols; Clinical Trials as Topic; Delayed-Action Preparations; Dopa Decarboxylase; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Humans; Levodopa; Nitriles; Parkinson Disease	2006
Long-term care of Parkinson's disease. Strategies for managing "wearing off" symptom re-emergence and dyskinesias. Geriatrics, 2006, Volume: 61, Issue:9 Topics: Antiparkinson Agents; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Long-Term Care; Nitriles; Parkinson Disease	2006
[Prevention and treatment of fluctuations in patients with Parkinson's disease]. Praxis, 2006, Dec-20, Volume: 95, Issue:51-52 Topics: Antiparkinson Agents; Apomorphine; Carbidopa; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dopamine Agonists; Drug Administration Routes; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Infusion Pumps, Implantable; Levodopa; Monoamine Oxidase Inhibitors; Neurologic Examination; Parkinson Disease; Treatment Outcome	2006
Role of the pharmacist in the effective management of wearing-off in Parkinson's disease. The Annals of pharmacotherapy, 2007, Volume: 41, Issue:11 Topics: Antiparkinson Agents; Carbidopa; Catechols; Dopamine Agonists; Drug Combinations; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Monoamine Oxidase Inhibitors; Nitriles; Parkinson Disease; Patient Education as Topic; Pharmacists; Professional Role; Severity of Illness Index	2007
Animal models of tardive dyskinesia: their use in the search for new treatment methods. Modern problems of pharmacopsychiatry, 1983, Volume: 21 Topics: Age Factors; Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Carbidopa; Corpus Striatum; Disease Models, Animal; Dopamine; Drug Combinations; Drug Interactions; Dyskinesia, Drug-Induced; Guinea Pigs; Haloperidol; Haplorhini; Humans; Levodopa; Lithium; Male; Parasympatholytics; Rats; Receptors, Dopamine; Stereotyped Behavior	1983
Medical treatment of later-stage motor problems of Parkinson disease. Mayo Clinic proceedings, 1999, Volume: 74, Issue:12 Topics: Amantadine; Antiparkinson Agents; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Cholinergic Antagonists; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Combinations; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Humans; Levodopa; Nitriles; Nitrophenols; Parkinson Disease, Secondary; Propranolol; Randomized Controlled Trials as Topic; Selegiline; Tolcapone	1999
Medical treatment of Parkinson's disease. Comprehensive therapy, 1989, Volume: 15, Issue:3 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease	1989

Trials

16 trial(s) available for carbidopa and Dyskinesia, Drug-Induced

Article	Year
Continuous Subcutaneous Levodopa Delivery for Parkinson's Disease: A Randomized Study. Journal of Parkinson's disease, 2021, Volume: 11, Issue:1 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Dyskinesia, Drug-Induced; Feasibility Studies; Female; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Severity of Illness Index; Single-Blind Method	2021
Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients. Movement disorders : official journal of the Movement Disorder Society, 2016, Volume: 31, Issue:4 Topics: Administration, Mucosal; Aged; Antiparkinson Agents; Carbidopa; Double-Blind Method; Drug Combinations; Dyskinesia, Drug-Induced; Female; Gels; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Treatment Outcome	2016
Quality of life in early Parkinson's disease treated with levodopa/carbidopa/entacapone. Movement disorders : official journal of the Movement Disorder Society, 2009, Jan-15, Volume: 24, Issue:1 Topics: Aged; Antiparkinson Agents; Benserazide; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Female; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Quality of Life; Severity of Illness Index; Treatment Outcome	2009
Long-term experience with continuous duodenal levodopa-carbidopa infusion (Duodopa): report of six patients. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2009, Volume: 30, Issue:1 Topics: Aged; Antiparkinson Agents; Carbidopa; Dose-Response Relationship, Drug; Drug Administration Schedule; Duodenum; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Infusion Pumps; Levodopa; Male; Middle Aged; Parkinson Disease; Time; Time Factors; Treatment Outcome	2009
Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study. Annals of neurology, 2010, Volume: 68, Issue:1 Topics: Antiparkinson Agents; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Disease Progression; Dopamine Agents; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Female; Humans; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Risk; Time Factors; Treatment Outcome	2010
[Pharmacotherapy of motor manifestations in late stages of Parkinson's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2010, Volume: 110, Issue:11 Pt 1 Topics: Aged; Carbidopa; Catechols; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	2010
Randomized trial of pallidotomy versus medical therapy for Parkinson's disease. Annals of neurology, 2003, Volume: 53, Issue:5 Topics: Antiparkinson Agents; Atrophy; Brain; Carbidopa; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Combinations; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Globus Pallidus; Humans; Hypokinesia; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Muscle Rigidity; Neurosurgical Procedures; Parkinson Disease; Severity of Illness Index; Treatment Outcome; Tremor	2003
Quality of life in early Parkinson's disease: impact of dyskinesias and motor fluctuations. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:1 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Carbidopa; Double-Blind Method; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Pain Measurement; Parkinson Disease; Pramipexole; Quality of Life; Thiazoles	2004
Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease. Neurology, 2005, Jan-25, Volume: 64, Issue:2 Topics: Administration, Oral; Adult; Aged; Antiparkinson Agents; Carbidopa; Cross-Over Studies; Drug Therapy, Combination; Duodenum; Dyskinesia, Drug-Induced; Female; Gels; Humans; Intubation; Levodopa; Male; Middle Aged; Parkinson Disease; Psychomotor Performance; Quality of Life; Severity of Illness Index; Single-Blind Method; Surveys and Questionnaires; Suspensions; Videotape Recording	2005
Dyskinesias associated with lithium therapy in parkinsonism. Clinical neuropharmacology, 1984, Volume: 7, Issue:3 Topics: Adult; Aged; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Lithium; Male; Middle Aged; Parkinson Disease; Random Allocation	1984
Serotonin precursor effects in tardive dyskinesia. Psychopharmacology, 1982, Volume: 77, Issue:3 Topics: 5-Hydroxytryptophan; Adult; Aged; Carbidopa; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Serotonin	1982
A trial of dextromethorphan in parkinsonian patients with motor response complications. Movement disorders : official journal of the Movement Disorder Society, 1998, Volume: 13, Issue:3 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Carbidopa; Cross-Over Studies; Dextromethorphan; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Motor Skills; N-Methylaspartate; Neurologic Examination; Parkinson Disease	1998
Implications of the 5-year CR FIRST trial. Sinemet CR Five-Year International Response Fluctuation Study. Neurology, 1998, Volume: 50, Issue:6 Suppl 6 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease	1998
Cyproheptadine in levodopa-induced dyskinesia in parkinsonism. Clinical pharmacology and therapeutics, 1978, Volume: 23, Issue:2 Topics: Aged; Carbidopa; Cyproheptadine; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1978
Stable remission of tardive dyskinesia by L-dopa. Journal of clinical psychopharmacology, 1989, Volume: 9, Issue:1 Topics: Adult; Aged; Antipsychotic Agents; Carbidopa; Chronic Disease; Clinical Trials as Topic; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Schizophrenia	1989
Controlled-release Sinemet (CR-4): a double-blind crossover study in patients with fluctuating Parkinson's disease. Mayo Clinic proceedings, 1988, Volume: 63, Issue:9 Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Clinical Trials as Topic; Consumer Behavior; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Drug Evaluation; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation; Time Factors	1988

Other Studies

61 other study(ies) available for carbidopa and Dyskinesia, Drug-Induced

Article	Year
Complex dyskinesias in Parkinson patients on levodopa/carbidopa intestinal gel. Parkinsonism & related disorders, 2019, Volume: 69 Topics: Aged; Antiparkinson Agents; Carbidopa; Case-Control Studies; Cross-Sectional Studies; Drug Combinations; Dyskinesia, Drug-Induced; Female; Gels; Humans; Intestines; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Retrospective Studies	2019
Liquid levodopa-carbidopa in advanced Parkinson's disease with motor complications. Journal of the neurological sciences, 2017, Jun-15, Volume: 377 Topics: Aged; Antiparkinson Agents; Ascorbic Acid; Carbidopa; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Kaplan-Meier Estimate; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Treatment Outcome	2017
Motor fluctuations and levodopa-induced dyskinesias in dopa-responsive dystonia. Parkinsonism & related disorders, 2018, Volume: 50 Topics: Carbidopa; Dopamine Agonists; Drug Combinations; Dyskinesia, Drug-Induced; Dystonic Disorders; Female; GTP Cyclohydrolase; Humans; Levodopa; Middle Aged	2018
Evaluation of D1/D5 Partial Agonist PF-06412562 in Parkinson's Disease following Oral Administration. Neuro-degenerative diseases, 2018, Volume: 18, Issue:5-6 Topics: Administration, Oral; Aged; Antiparkinson Agents; Carbidopa; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Treatment Outcome	2018
Sitagliptin and Liraglutide Modulate L-dopa Effect and Attenuate Dyskinetic Movements in Rotenone-Lesioned Rats. Neurotoxicity research, 2019, Volume: 35, Issue:3 Topics: Animals; Antiparkinson Agents; Carbidopa; Corpus Striatum; Dopamine; Drug Combinations; Dyskinesia, Drug-Induced; Levodopa; Liraglutide; Male; Motor Activity; Parkinsonian Disorders; Pars Compacta; Random Allocation; Rats, Wistar; Rotenone; Sitagliptin Phosphate	2019
Cholinergic manipulation of motor disability and L-DOPA-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated common marmosets. Journal of neural transmission (Vienna, Austria : 1996), 2014, Volume: 121, Issue:2 Topics: Animals; Antiparkinson Agents; Callithrix; Carbidopa; Cholinergic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Levodopa; Male; Motor Activity; MPTP Poisoning; Statistics, Nonparametric	2014
Dyskinesias during levodopa-carbidopa intestinal gel (LCIG) infusion: Management inclinical practice. Parkinsonism & related disorders, 2015, Volume: 21, Issue:3 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Dyskinesia, Drug-Induced; Gels; Humans; Jejunum; Levodopa; Parkinson Disease	2015
[Experience with levodopa/carbidopa intestinal gel in the treatment of advanced Parkinson's disease in Hungary]. Ideggyogyaszati szemle, 2014, Nov-30, Volume: 67, Issue:11-12 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Gels; Humans; Hungary; Intestines; Levodopa; Male; Middle Aged; Parkinson Disease; Patient Selection; Quality of Life; Retrospective Studies; Time Factors; Treatment Outcome	2014
Long-term response to continuous duodenal infusion of levodopa/carbidopa gel in patients with advanced Parkinson disease: The Barcelona registry. Parkinsonism & related disorders, 2015, Volume: 21, Issue:8 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Duodenum; Dyskinesia, Drug-Induced; Dyskinesias; Female; Follow-Up Studies; Gels; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Parkinson Disease; Registries; Spain; Treatment Outcome	2015
Diphasic dyskinesias during levodopa-carbidopa intestinal gel (LCIG) infusion in Parkinson's disease. Parkinsonism & related disorders, 2017, Volume: 37 Topics: Aged; Antiparkinson Agents; Carbidopa; Disability Evaluation; Drug Combinations; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Gels; Humans; Intestines; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index	2017
Dyskinesias in levodopa-carbidopa intestinal gel infusion era: New challenges, new features. Movement disorders : official journal of the Movement Disorder Society, 2017, Volume: 32, Issue:4 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	2017
[Long term experience with Stalevo in Szeged, Hungary]. Ideggyogyaszati szemle, 2009, May-30, Volume: 62, Issue:5-6 Topics: Aged; Antiparkinson Agents; Carbidopa; Catechols; Drug Combinations; Drug Resistance; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Pain Measurement; Parkinson Disease; Quality of Life; Severity of Illness Index; Time Factors; Treatment Outcome	2009
Three year follow up of levodopa plus carbidopa treatment in a prevalent cohort of patients with Parkinson's disease in Hai, Tanzania. Journal of neurology, 2011, Volume: 258, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Cohort Studies; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prevalence; Retrospective Studies; Tanzania	2011
Lees' syndrome: a case series. Arquivos de neuro-psiquiatria, 2011, Volume: 69, Issue:5 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Dopamine; Dopamine Agents; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Syndrome	2011
Treatment of Parkinson disease: a 64-year-old man with motor complications of advanced Parkinson disease. JAMA, 2012, Jun-06, Volume: 307, Issue:21 Topics: Amantadine; Antiparasitic Agents; Carbidopa; Catechols; Decision Making; Deep Brain Stimulation; Disease Progression; Dyskinesia, Drug-Induced; Gait Disorders, Neurologic; Globus Pallidus; Humans; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Quality of Life; Subthalamus	2012
Foot dystonia heralding levodopa-induced dyskinesias in Parkinson disease. Clinical neurology and neurosurgery, 2013, Volume: 115, Issue:2 Topics: Antiparkinson Agents; Carbidopa; Catechols; Dyskinesia, Drug-Induced; Dystonia; Female; Foot Diseases; Humans; Levodopa; Middle Aged; Neurologic Examination; Nitriles; Parkinson Disease	2013
Effect of pulsatile administration of levodopa on dyskinesia induction in drug-naïve MPTP-treated common marmosets: effect of dose, frequency of administration, and brain exposure. Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:5 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Callithrix; Carbidopa; Catechols; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Levodopa; Locomotion; Male; Nitriles; Parkinsonian Disorders; Pulse Therapy, Drug; Substantia Nigra; Time Factors	2003
The monoamine reuptake inhibitor BTS 74 398 fails to evoke established dyskinesia but does not synergise with levodopa in MPTP-treated primates. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:1 Topics: Animals; Antiparkinson Agents; Callithrix; Carbidopa; Chlorobenzenes; Cyclobutanes; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Dyskinesia, Drug-Induced; Levodopa; Locomotion; Male; Motor Activity; Motor Skills; Neurologic Examination; Parkinsonian Disorders; Postural Balance; Stereotyped Behavior	2004
Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP-treated drug-naive primates. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Callithrix; Carbidopa; Catechols; Dopamine Agents; Drug Administration Schedule; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Injections, Subcutaneous; Levodopa; Locomotion; Male; MPTP Poisoning; Nitriles; Severity of Illness Index; Substantia Nigra; Time Factors	2005
Carbidopa/levodopa therapy of coexistent drug-induced parkinsonism and tardive dyskinesia. Advances in neurology, 1983, Volume: 37 Topics: Aged; Antipsychotic Agents; Carbidopa; Drug Combinations; Drug Evaluation; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Outcome and Process Assessment, Health Care; Parkinson Disease; Parkinson Disease, Secondary	1983
Dopamine agonists in clinical research for new tardive dyskinesia treatments. Modern problems of pharmacopsychiatry, 1983, Volume: 21 Topics: Adult; Aged; Antipsychotic Agents; Apomorphine; Benserazide; Carbidopa; Dopamine; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Hydrazines; Levodopa; Middle Aged; Synaptic Transmission	1983
Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy. The Journal of clinical psychiatry, 1984, Volume: 45, Issue:1 Topics: Aged; Antipsychotic Agents; Carbidopa; Corpus Striatum; Depressive Disorder; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Metoclopramide; Parkinson Disease, Secondary; Receptors, Dopamine	1984
What to do when Sinemet fails: Part one. Clinical neuropharmacology, 1984, Volume: 7, Issue:2 Topics: Antiparkinson Agents; Carbidopa; Dementia; Drug Administration Schedule; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Psychoses, Substance-Induced	1984
Behavioral control of L-dopa induced dyskinesia in Parkinsonism. Biofeedback and self-regulation, 1982, Volume: 7, Issue:4 Topics: Adult; Antiparkinson Agents; Biofeedback, Psychology; Carbidopa; Drug Combinations; Dyskinesia, Drug-Induced; Electromyography; Humans; Levodopa; Male; Relaxation Therapy	1982
[Experimental studies on L-dopa induced dyskinesia (author's transl)]. No to shinkei = Brain and nerve, 1980, Volume: 32, Issue:2 Topics: Animals; Carbidopa; Chlorocebus aethiops; Dyskinesia, Drug-Induced; Haplorhini; Levodopa; Motor Activity; Nystagmus, Pathologic	1980
Long-term treatment of tardive dyskinesia with presynaptically acting dopamine-depleting agents. Advances in neurology, 1983, Volume: 37 Topics: Adult; Aged; alpha-Methyltyrosine; Carbidopa; Dopamine; Dopamine Antagonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Methyltyrosines; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Reserpine; Synapses; Tetrabenazine	1983
The effect of chronic levodopa on haloperidol induced behavioral supersensitivity in the guinea pig. Life sciences, 1981, May-11, Volume: 28, Issue:19 Topics: Animals; Apomorphine; Behavior, Animal; Carbidopa; Dyskinesia, Drug-Induced; Guinea Pigs; Haloperidol; Humans; Levodopa; Male; Stereotyped Behavior; Time Factors	1981
Parkinsonism and bipolar affective disorder. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1995, Volume: 40, Issue:3 Topics: Aged; Antiparkinson Agents; Bipolar Disorder; Carbidopa; Clonazepam; Dopamine; Drug Combinations; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Lithium Carbonate; Male; Parkinson Disease, Secondary	1995
Adverse reactions to Sinemet CR. Journal of the American Geriatrics Society, 1995, Volume: 43, Issue:8 Topics: Aged; Antiparkinson Agents; Carbidopa; Confusion; Delayed-Action Preparations; Drug Combinations; Dyskinesia, Drug-Induced; Hallucinations; Humans; Levodopa	1995
Anticholinergics and dyskinesia. Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:6 Topics: Aged; Biperiden; Carbidopa; Drug Combinations; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Neurologic Examination; Parkinson Disease; Tremor; Trihexyphenidyl	1994
Portable device for quantifying parkinsonian wrist rigidity. Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:1 Topics: Adult; Aged; Antiparkinson Agents; Antipsychotic Agents; Carbidopa; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Muscle Tonus; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Psychotic Disorders; Risk Factors; Transducers	1994
Role of selective D1 and D2 agonists in inducing dyskinesia in drug-naive MPTP monkeys. Advances in neurology, 1993, Volume: 60 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Brain Mapping; Carbidopa; Corpus Striatum; Dopamine Agents; Dose-Response Relationship, Drug; Down-Regulation; Drug Combinations; Dyskinesia, Drug-Induced; Female; Levodopa; Locomotion; Macaca fascicularis; Parkinson Disease, Secondary; Psychomotor Performance; Receptors, Dopamine D1; Receptors, Dopamine D2	1993
Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment. Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:2 Topics: Aged; Antiparkinson Agents; Bromocriptine; Carbidopa; Chorea; Circadian Rhythm; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease	1994
Risk factors for motor response complications in L-dopa-treated parkinsonian patients. Advances in neurology, 1993, Volume: 60 Topics: Adult; Age Factors; Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Levodopa; Long-Term Care; Male; Middle Aged; Motor Activity; Neurologic Examination; Parkinson Disease; Risk Factors	1993
Developing a stable bilateral model of parkinsonism in rhesus monkeys. Neuroscience, 1993, Volume: 52, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Carbidopa; Carotid Arteries; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Feeding Behavior; Female; Injections, Intra-Arterial; Levodopa; Macaca mulatta; Motor Activity; Parkinson Disease, Secondary	1993
Does tolerance develop to levodopa? Comparison of 2- and 21-H levodopa infusions. Movement disorders : official journal of the Movement Disorder Society, 1993, Volume: 8, Issue:2 Topics: Aged; Carbidopa; Chromatography, High Pressure Liquid; Drug Administration Schedule; Drug Tolerance; Dyskinesia, Drug-Induced; Female; Humans; Infusions, Intravenous; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Tyrosine	1993
Worsening of postural tremor in patients with levodopa-induced dyskinesia: a quantitative analysis. Clinical neuropharmacology, 1993, Volume: 16, Issue:3 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Levodopa; Male; Middle Aged; Posture; Tremor	1993
High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias. Movement disorders : official journal of the Movement Disorder Society, 1996, Volume: 11, Issue:3 Topics: Aged; Antiparkinson Agents; Carbidopa; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Pergolide	1996
Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix Jacchus). Movement disorders : official journal of the Movement Disorder Society, 1995, Volume: 10, Issue:6 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Oral; Animals; Antiparkinson Agents; Callithrix; Carbidopa; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Synergism; Dyskinesia, Drug-Induced; Female; Levodopa; Male; Neurologic Examination; Parkinson Disease, Secondary	1995
Validation of a rodent model of Parkinson's Disease: evidence of a therapeutic window for oral Sinemet. Brain research bulletin, 1996, Volume: 39, Issue:6 Topics: Administration, Oral; Animals; Antiparkinson Agents; Carbidopa; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation, Preclinical; Dyskinesia, Drug-Induced; Levodopa; Male; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Stereotyped Behavior	1996
Clinical implications of sustained dopaminergic stimulation. Clinical neuropharmacology, 1994, Volume: 17 Suppl 2 Topics: Aged; Benserazide; Carbidopa; Delayed-Action Preparations; Dopamine Agonists; Drug Combinations; Dyskinesia, Drug-Induced; Follow-Up Studies; Humans; Levodopa; Lisuride; Parkinson Disease; Reaction Time	1994
Altered thalamic response to levodopa in Parkinson's patients with dopa-induced dyskinesias. Proceedings of the National Academy of Sciences of the United States of America, 1998, Sep-29, Volume: 95, Issue:20 Topics: Adult; Aged; Carbidopa; Case-Control Studies; Cerebrovascular Circulation; Dyskinesia, Drug-Induced; Female; Globus Pallidus; Humans; Levodopa; Male; Middle Aged; Motor Cortex; Parkinson Disease; Thalamus; Tomography, Emission-Computed	1998
Internal globus pallidus discharge is nearly suppressed during levodopa-induced dyskinesias. Annals of neurology, 1999, Volume: 46, Issue:5 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Carbidopa; Drug Combinations; Dyskinesia, Drug-Induced; Dyskinesias; Electrophysiology; Eye Movements; Globus Pallidus; Levodopa; Macaca mulatta; Motor Activity; Neurons; Parkinsonian Disorders	1999
Combined use of the adenosine A(2A) antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys. Experimental neurology, 2000, Volume: 162, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Oral; Animals; Callithrix; Carbidopa; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Injections, Intraperitoneal; Levodopa; Male; Motor Activity; Parkinson Disease, Secondary; Purinergic P1 Receptor Antagonists; Purines; Quinpirole; Receptor, Adenosine A2A; Receptors, Dopamine D1; Receptors, Dopamine D2	2000
Therapeutics of disordered movement. American family physician, 1977, Volume: 16, Issue:3 Topics: Carbidopa; Chorea; Drug Administration Schedule; Dyskinesia, Drug-Induced; Dystonia Musculorum Deformans; Hepatolenticular Degeneration; Humans; Huntington Disease; Levodopa; Movement Disorders; Parasympatholytics; Parkinson Disease; Receptors, Cholinergic; Receptors, Dopamine; Tremor	1977
New approaches in the management of hyperkinetic movement disorders. Advances in experimental medicine and biology, 1977, Volume: 90 Topics: 5-Hydroxytryptophan; Carbidopa; Chorea; Dyskinesia, Drug-Induced; Humans; Movement Disorders; Myoclonus; Propranolol; Receptors, Dopamine; Torticollis; Tranquilizing Agents; Tremor	1977
Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats. Life sciences, 1979, Apr-16, Volume: 24, Issue:16 Topics: Animals; Apomorphine; Bromocriptine; Carbidopa; Corpus Striatum; Dyskinesia, Drug-Induced; Haloperidol; Levodopa; Male; Radioligand Assay; Rats; Receptors, Dopamine; Receptors, Drug; Spiperone	1979
Plasma O-methyldopa in levodopa-induced dyskinesias. A bioclinical investigation. Acta neurologica Scandinavica, 1977, Volume: 56, Issue:6 Topics: Aged; Benserazide; Carbidopa; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Methyldopa; Middle Aged; Parkinson Disease	1977
Receptor-cell sensitivity modification (RSM) as a model for pathogenesis and treatment of tardive dyskinesia. Psychopharmacology bulletin, 1978, Volume: 14, Issue:4 Topics: Animals; Carbidopa; Disease Models, Animal; Drug Combinations; Dyskinesia, Drug-Induced; Hydrazines; Levodopa; Rats; Receptors, Dopamine	1978
Does O-methyl-dopa play a role in levodopa-induced dyskinesias? Acta neurologica Scandinavica, 1977, Volume: 56, Issue:1 Topics: Adult; Aged; Benserazide; Carbidopa; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Methyldopa; Middle Aged; Parkinson Disease	1977
Controlled-release carbidopa-levodopa: old drug--new drug. Introduction. Neurology, 1992, Volume: 42, Issue:1 Suppl 1 Topics: Carbidopa; Circadian Rhythm; Delayed-Action Preparations; Dyskinesia, Drug-Induced; Evaluation Studies as Topic; Humans; Levodopa; Parkinson Disease	1992
The use of Sinemet CR in the management of mild to moderate Parkinson's disease. Neurology, 1992, Volume: 42, Issue:1 Suppl 1 Topics: Carbidopa; Drug Administration Schedule; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Levodopa; Movement; Parkinson Disease; Patient Compliance; Patient Education as Topic; Tissue Distribution	1992
Naloxone reverses L-dopa induced overstimulation effects in a Parkinson's disease animal model analogue. Life sciences, 1991, Volume: 48, Issue:13 Topics: Animals; Carbidopa; Chromatography, High Pressure Liquid; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Hydroxydopamines; Levodopa; Male; Mesencephalon; Naloxone; Oxidopamine; Parkinson Disease; Rats; Rats, Inbred Strains; Time Factors	1991
New concepts in the treatment of Parkinson's disease. American family physician, 1990, Volume: 41, Issue:2 Topics: Antiparkinson Agents; Carbidopa; Diet; Dopamine Agents; Drug Administration Schedule; Dyskinesia, Drug-Induced; Humans; Intestinal Absorption; Levodopa; Parkinson Disease; Selegiline	1990
Preliminary report on adrenal medullary grafting and cografting with sural nerve in the treatment of hemiparkinson monkeys. Progress in brain research, 1990, Volume: 82 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenal Medulla; Animals; Apomorphine; Behavior, Animal; Carbidopa; Caudate Nucleus; Disease Models, Animal; Dopamine; Dyskinesia, Drug-Induced; Levodopa; Macaca mulatta; Motor Activity; Parkinson Disease; Sural Nerve; Transplantation, Heterotopic	1990
Severity of Parkinson's disease is a risk factor for peak-dose dyskinesia. Journal of neurology, neurosurgery, and psychiatry, 1990, Volume: 53, Issue:3 Topics: Aged; Antiparkinson Agents; Benserazide; Carbidopa; Carboxy-Lyases; Dose-Response Relationship, Drug; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Hydrazines; Levodopa; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease	1990
Adrenal medullary autograft transplantation into the striatum of patients with Parkinson's disease. Mayo Clinic proceedings, 1989, Volume: 64, Issue:3 Topics: Adrenal Medulla; Adult; Carbidopa; Caudate Nucleus; Drug Combinations; Dyskinesia, Drug-Induced; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Postoperative Complications; Stereotaxic Techniques	1989
Levodopa and 3-O-methyldopa plasma levels in parkinsonian patients with stable and fluctuating motor response. Clinical neuropharmacology, 1989, Volume: 12, Issue:1 Topics: Aged; Carbidopa; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Tyrosine	1989
Painful Parkinson's disease. Lancet (London, England), 1986, Jun-14, Volume: 1, Issue:8494 Topics: Acute Disease; Adult; Aged; Antiparkinson Agents; Benserazide; Carbidopa; Drug Administration Schedule; Drug Combinations; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Pain; Parkinson Disease; Time Factors	1986
Parkinson's disease. Comprehensive therapy, 1986, Volume: 12, Issue:3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amantadine; Animals; Benserazide; Carbidopa; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parasympatholytics; Parkinson Disease; Parkinson Disease, Secondary; Pyridines; Rats	1986
Levodopa-induced dyskinesia: clinical observations. Journal of neurology, 1985, Volume: 232, Issue:1 Topics: Adult; Aged; Carbidopa; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Risk	1985